Analyst Views on $ERAS
Neutral 1
$ERAS options pricing anticipates a large stock move heading into the November 20 clinical data announcement, without specifying an upside or downside direction.
$ERAS options pricing anticipates a large stock move heading into the November 20 clinical data announcement, without specifying an upside or downside direction.
Comments
0 REMARKS